Bioniche Pharma Acquires Baxter's ENLON and ENLON-PLUS

Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, announced today the acquisition of Baxter Healthcare Corporation's ENLON product line, including: -- ENLON(R) (edrophonium chloride injection, USP) 10 mg/mL, 15 mL vial
-- ENLON-PLUS(R) (edrophonium chloride, USP and atropine sulfate, USP) Injection 5 mL ampule
-- ENLON-PLUS(R) (edrophonium chloride, USP and atropine sulfate, USP) Injection, 15 mL Multi-dose Vial.

The details can be read here.